Superworth

Protara Therapeutics market cap TARA

Share price times shares outstanding: what the whole company sells for, since 2014.

Today, Nov 2, 2026
$142.4M
Highest close in our data
$329M
Jul 2015

Protara Therapeutics is worth $142.4M at the close on Nov 2, 2026, at $2.41 a share.

That is down 14% over the last year and up 78% over five years.

Its highest close in our data was $329M in Jul 2015.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$142.4M$137.1M$294.2M−33%
2025$214.2M$76.7M$284.8M+88%
2024$113.7M$21.7M$123.4M+432%
2023$21.4M$13.1M$43.6M−29%
2022$30.2M$29.4M$71.6M−60%
2021$75.8M$70.7M$244.5M−72%
2020$271.4M$9.2M$317.9M+3750%
2019$7.1M$4.9M$70M−84%
2018$43.2M$28M$48.6M+29%
2017$33.5M$20.1M$46.7M+6%
2016$31.5M$31.5M$194M−88%
2015$255.7M$171.9M$329M+58%
2014$161.5M$144.3M$173.4Mn/a

Against its peers

Companies in Healthcare nearest Protara Therapeutics' size, closest first, today.

CompanyMarket cap
TARAProtara Therapeutics$142.4M
PDEXPro DEX$184.5M
PLXProtalix BioTherapeutics$206.3M
KEQUKewaunee Scientific$96.7M
ICCCImmucell$95.9M
NATRNatures Sunshine Products$211.5M
ELMDElectromed$223.9M
UTMDUtah Medical Products$224.6M
INFUInfuSystem$275.7M
LFVNLifevantage$73.5M
CYHCommunity Health Systems$296.2M
Peer median$208.9M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Protara Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.